NMD Pharma: Funding, Investors & Team (Sep 2026)
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise. Importantly, the approach improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
NMD Pharma has raised $39.7M across 1 funding round on record, the most recent an undisclosed round of $39.7M announced in Feb 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NMD Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2022.
NMD Pharma Funding Rounds
NMD Pharma Founders and Leadership Team
No contact details are on record for this team yet.
NMD Pharma Funding Compared to Other Biotechnology Startups
NMD Pharma's latest round of $39.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NMD Pharma in Biotechnology and Risskov
Companies Similar to NMD Pharma
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
NMD Pharma Funding FAQs
What does NMD Pharma do?
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise. Importantly, the approach improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
How much funding has NMD Pharma raised?
NMD Pharma has raised $39.7M across 1 round on record. The most recent is an undisclosed round of $39.7M announced in Feb 2022.
When did NMD Pharma last raise funding?
NMD Pharma's most recent funding round on record is an undisclosed round of $39.7M, announced in Feb 2022.
Who is the CEO of NMD Pharma?
Thomas Holm Pedersen is listed as CEO at NMD Pharma.
Where is NMD Pharma headquartered?
NMD Pharma is based in Risskov, Midtjylland, Denmark.
How many employees does NMD Pharma have?
NMD Pharma is in the 11-50 employee band.
How does NMD Pharma's funding compare to other Biotechnology startups?
NMD Pharma's latest round of $39.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's NMD Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NMD Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.